Harvard Apparatus Regenerative Technology Inc. (OTCPK: HRGN)
Health Care · Biotechnology · US
$2.19
+11.17% today · +14.7% 1Y
Harvard Apparatus Regenerative Technology Inc. (OTCPK: HRGN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $44.42M and employs 8 people.
Over the last twelve months the share price has gained 14.7%, trading between 0.96 and 2.46.
Tweenvest scores Harvard Apparatus Regenerative Technology Inc. across four factors: quality 33/100, value 75/100. Its strongest factor is value.
HRGN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.42M
- Revenue (TTM)
- $982.00K
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- -0.39
- 52-week high
- $2.46
- 52-week low
- $0.96
- Avg volume (3M)
- —
- Shares outstanding
- 20.28M
- Employees
- 8
- Next earnings
- —
About Harvard Apparatus Regenerative Technology Inc.
Harvard Apparatus Regenerative Technology Inc., a biotechnology firm currently conducting clinical trials, is dedicated to developing regenerative medical therapies. Its core mission involves addressing conditions affecting the gastrointestinal system and various other organs, which may stem from cancer, trauma, or congenital defects. The company's primary experimental therapy, the Cellspan Esophageal Implant, aims to treat severe esophageal disease. Beyond this, its development pipeline encompasses organ-regeneration technologies designed for the repair or replacement of damaged or diseased organs. This includes product candidates targeting diverse esophageal ailments—such as those caused by traumatic injury, caustic burns, or tissue damage from chemoradiation therapy, as well as birth defects—and solutions for colon and uterine wound reconstruction. Additionally, the company offers consumer health products, including dietary supplements, focusing on personal wellness. Founded in 2009 and headquartered in Holliston, Massachusetts, the company operated as Biostage, Inc. until its rebranding to Harvard Apparatus Regenerative Technology Inc. in July 2023.
- ISIN
- US09074M2026
- Founded
- 2009
- Listed since
- Oct 21, 2013
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Norda ASAOTCNO: NORD | $45.37M | Nkr85.10 | — |
| Adocia SAENXTPA: ADOC | $45.24M | €2.04 | -1.26% |
| Werewolf Therapeutics, Inc.NasdaqCM: HOWL | $45.10M | $0.92 | -0.86% |
| GenMont Biotech IncorporationTWSE: 3164 | $44.55M | NT$16.50 | +1.23% |
| Biomolecular Life Holdings, Inc.OTCPK: BIOM | $43.49M | $0.85 | +80.85% |
| NurExone Biologic Inc.TSXV: NRX | $43.29M | CA$0.59 | -7.81% |
| BrightPath Biotherapeutics Co., Ltd.TSE: 4594 | $43.15M | ¥49.00 | -3.92% |
| KoBioLabs, IncKOSDAQ: A348150 | $43.11M | ₩2,990.00 | +12.20% |
Figures last refreshed Oct 4, 2026.